Hope Rugo

2.0k citations
5 papers · 193 indexed · h-index 4
Topics
Cancer Treatment and Pharmacology (3 papers)HER2/EGFR in Cancer Research (1 paper)Advanced Breast Cancer Therapies (1 paper)
Partner nations
United StatesSpainItaly

In The Last Decade

Hope Rugo

5 papers receiving 187 citations

Peers

Hope Rugo
Comparison fields: 5 of 44
  • Radiology, Nuclear Medicine and Imaging 91
  • Oncology 80
  • Cancer Research 80
  • Pathology and Forensic Medicine 50
  • Dermatology 19
Replace Makbule Tambaş with:
Makbule Tambaş Türkiye
Natasha Mithal United Kingdom
Havva Yeşil Çınkır Türkiye
Julie Kepple United States
Hyuk Jai Shin South Korea
Chad Winch Canada
Aimée Herzog Germany
Susanne Kohlfürst Austria
Fiorella Ruatta Italy
Lena Tennvall-Nittby Sweden
Hope Rugo relative to Makbule Tambaş Türkiye Makbule Tambaş's profile →
Citations per field
00.5×1.5×2.3×
Makbule Tambaş · 1×
Citations per year

Countries citing papers authored by Hope Rugo

Since Specialization
Citations

This map shows the geographic impact of Hope Rugo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hope Rugo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hope Rugo more than expected).

Fields of papers citing papers by Hope Rugo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hope Rugo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hope Rugo. The network helps show where Hope Rugo may publish in the future.

Co-authorship network of co-authors of Hope Rugo

This figure shows the co-authorship network connecting the top 25 collaborators of Hope Rugo. A scholar is included among the top collaborators of Hope Rugo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hope Rugo. Hope Rugo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 6
2 5
3 1
4
The Modified Total Neuropathy Score: A Clinically Feasible and Valid Measure of Taxane-Induced Peripheral Neuropathy in Women With Breast Cancer
59
5 122

About Hope Rugo

Hope Rugo is a scholar working on Oncology, Dermatology and Radiology, Nuclear Medicine and Imaging, having authored 5 papers that have together received 193 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Cancer Research (80 citations), Radiology, Nuclear Medicine and Imaging (91 citations) and Oncology (80 citations). Hope Rugo has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Christine Miaskowski, Nancy N. Byl, Kimberly Topp, Debasish Tripathy, Henry M. Kuerer, Laura Esserman, John Park, Shelley Hwang, Ying Lü and Nola M. Hylton. Their work appears in journals such as Cancer Research and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026